Leaders in Biopharmaceutical Innovation
Our leadership team is a coalition of disruptors with over 150 years of combined R&D experience and a history of delivering two of the 10 largest biopharma deals of the last century. They are committed to advancing the future of medicine, creating approved medicines, and consistently delivering value to our shareholders.
Dr. Greg Bailey
Co-founder, Executive Chairman
Jim Mellon
Co-founder, Deputy Chairman
Dr. Declan Doogan
Co-founder, Board Member
Dr. Richard Marshall
Chief Executive Officer
Dr. Gillian Dines
Chief Science Officer
Dr. Steve Felstead
Chief Medical Officer
Dr. Jeff Madwed
Senior Project Lead
David Gill
Chief Financial Officer
Alexander Pickett
Managing Director
Juvenescence Leadership Instrumental In Development Of Medicines With Peak Annual Sales Of $30bn